Conexeu Sciences Inc. (CNXU)

Conexeu Sciences Advances Ten Minute Tissue™ Toward Planned FDA 510(k) Submission

A Wave of Weight-Loss Drugs Is Quietly Creating a Multi-Billion-Dollar Opportunity That Aesthetic Medicine Is Racing to Capture

Conexeu Sciences Sets September and October 2026 Conference Schedule

Conexeu Sciences Sees a New Category Forming in Medical Aesthetics as Research Turns to Regeneration

The GLP-1 Boom Created a $2 Billion Opening in Aesthetics. One Preclinical Biotech Is Building the Product to Fill It.

The GLP-1s Are Creating Another Boom, a New $2 Billion Opportunity Exists in Aesthetics. Conexeu Is Building for It

A $190 Billion Weight-Loss Boom Has Exposed a Tissue-Restoration Gap Today's Injectables Were Not Built to Fill